YDC-103

N/A

Report date: 2022/06/14 17:31:24
NME

Base Information

Drug NameYDC-103
Drug Alias NameYDC-103
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta amyloid A4 protein inhibitorsMicrotubule-associated protein tau inhibitors
TargetsBeta amyloid A4 proteinMicrotubule-associated protein tau
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesYd Global Life Science Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesYd Global Life Science Co Ltd
Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A